Second-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-rafts

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Ni, Inzer ^a,b   Ji, Changhoon ^a,b   Vij, Neeraj ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

^c Children's Hospital of Michigan   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; PASSIVE SMOKING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; BACTERIAL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; IMMUNOBLOTTING; IMMUNOMODULATION; LIPID RAFT; LONG TERM EXPOSURE; MACROPHAGE; MOUSE; NONHUMAN; PASSIVE SMOKING; PHAGOCYTOSIS; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; TRANSIENT TRANSFECTION; ADVERSE EFFECTS; ANIMAL; CELL MEMBRANE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GENETIC TRANSFECTION; METABOLISM; MICROBIOLOGY; RAW 264.7 CELL LINE;

BACTERIA (MICROORGANISMS); MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

ANIMALS; CELL SURVIVAL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MACROPHAGES; MEMBRANE MICRODOMAINS; MICE; PHAGOCYTOSIS; RAW 264.7 CELLS; TOBACCO SMOKE POLLUTION; TRANSFECTION;

EID: 84925859909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121200     Document Type: Article

References (72)

1. Filosto S, Castillo S, Danielson A, Franzi L, Khan E, Kenyon N, et al. Neutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury. Am J Respir Cell Mol Biol. 2011; 44: 350-360. doi: 10.1165/rcmb.2009-0422OC PMID: 20448054
2. Marin L, Colombo P, Bebawy M, Young PM, Traini D. Chronic obstructive pulmonary disease: pathophysiology, current methods of treatment and the potential for simvastatin in disease management. Expert Opin Drug Deliv. 2011; 8: 1205-1220. doi: 10.1517/17425247.2011.588697 PMID: 21615218
3. Barnes PJ. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLOS Med. 2007; 4: e112. PMID: 17503959
4. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006; 27: 397-412. PMID: 16452599
5. Taylor AE, Finney-Hayward TK, Quint JK, Thomas CM, Tudhope SJ, Wedzhica JA, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J. 2010; 35: 1039-1047. doi: 10.1183/09031936.00036709 PMID: 19897561
6. Bodas M, Min T, Vij N. Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury. Am J Physiol Lung Cell Mol Physiol. 2011; 300: L811-820. doi: 10.1152/ajplung.00408.2010 PMID: 21378025
7. Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL, et al. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J. 2012; 26: 533-545. doi: 10.1096/fj.11-192377 PMID: 21990373
8. Min T, Bodas M, Mazur S, Vij N. Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysema. J Mol Med. 2011; 89: 577-593. doi: 10.1007/s00109-011-0732-8 PMID: 21318260
9. Moodie FM, Marwick JA, Anderson CS, Szulakowski P, Biswas SK, Bauter MR, et al. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J. 2004; 18: 1897-1899. PMID: 15456740
10. Bagaitkar J, Demuth DR, Scott DA. Tobacco use increases susceptibility to bacterial infection. Tob Induc Dis. 2008; 4: 12. doi: 10.1186/1617-9625-4-12 PMID: 19094204
11. Li C, Schuetz JD, Naren AP. Tobacco carcinogen NNK transporter MRP2 regulates CFTR function in lung epithelia: implications for lung cancer. Cancer Lett. 2010; 292: 246-253. doi: 10.1016/j.canlet.2009.12.009 PMID: 20089353
12. Bodas M, Min T, Mazur S, Vij N. Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema. J Immunol. 2011; 186: 602-613. doi: 10.4049/jimmunol.1002850 PMID: 21135173
13. Sethi S, Mallia P, Johnston SL. New paradigms in the pathogenesis of chronic obstructive pulmonary disease II. Proc Am Thorac Soc. 2009; 6: 532-534. doi: 10.1513/pats.200905-025DS PMID: 19741263
14. Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD. 2004; 1: 59-70. PMID: 16997739
15. Donnelly LE, Barnes PJ. Defective phagocytosis in airways disease. Chest. 2012; 141: 1055-1062. doi: 10.1378/chest.11-2348 PMID: 22474147
16. Huvenne W, Lanckacker EA, Krysko O, Bracke KR, Demoor T, Hellings PW, et al. Exacerbation of cigarette smoke-induced pulmonary inflammation by Staphylococcus aureus enterotoxin B in mice. Respir Res. 2011; 12: 69. doi: 10.1186/1465-9921-12-69 PMID: 21615971
17. Drannik AG, Pouladi MA, Robbins CS, Goncharova SI, Kianpour S, Stampfli MR. Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med. 2004. 170: 1164-1171. PMID: 15317669
18. Phipps JC, Aronoff DM, Curtis JL, Goel D, O'Brien E, Mancuso P. Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun. 2010; 78: 1214-1220. doi: 10.1128/IAI.00963-09 PMID: 20008540
19. Dockrell DH, Marriott HM, Prince LR, Ridger VC, Ince PG, Hellewell PG, et al. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J Immunol. 2003; 171: 5380-5388. PMID: 14607941
20. Minematsu N, Blumental-Perry A, Shapiro SD. Cigarette smoke inhibits engulfment of apoptotic cells by macrophages through inhibition of actin rearrangement. Am J Respir Cell Mol Biol. 2011; 44: 474-482. doi: 10.1165/rcmb.2009-0463OC PMID: 20525804
21. Laurenzi GA, Guarneri JJ, Endriga RB, Carey JP. Clearance of Bacteria by the Lower Respiratory Tract. Science. 1963; 142: 1572-1573. PMID: 14075687
22. Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 177: 853-860. doi: 10.1164/rccm. 200709-1413OC PMID: 18202344
23. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2007; 37: 748-755. PMID: 17630319
24. Martinez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect. 2008; 47: 1526-1533. doi: 10.1086/593186 PMID: 18990062
25. Green GM, Carolin D. The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med. 1967; 276: 421-427. PMID: 6019163
26. Thomas WR, Holt PG, Keast D. Cigarette smoke and phagocyte function: effect of chronic exposure in vivo and acute exposure in vitro. Infect Immun. 1978; 20: 468-475. PMID: 97229
27. Williams BJ, Dehnbostel J, Blackwell TS. Pseudomonas aeruginosa: host defence in lung diseases. Respirology. 2010. 15: 1037-1056. doi: 10.1111/j.1440-1843.2010.01819.x PMID: 20723140
28. Dransfield MT, Wilhelm AM, Flanagan B, Courville C, Tidwell SL, Raju SV, et al. Acquired CFTR Dysfunction in the Lower Airways in COPD. Chest. 2013; 144: 498-506. doi: 10.1378/chest.13-0274 PMID: 23538783
29. Johannesson B, Hirtz S, Schatterny J, Schultz C, Mall MA. CFTR regulates early pathogenesis of chronic obstructive lung disease in betaENaC-overexpressing mice. PLOS One. 2012; 7: e44059. doi: 10.1371/journal.pone.0044059 PMID: 22937152
30. Moreau-Marquis S, Stanton BA, O'Toole GA. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulm Pharmacol Ther. 2008; 21: 595-599. doi: 10.1016/j.pupt.2007.12.001 PMID: 18234534
31. Deziel E, Comeau Y, Villemur R. Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities. J Bacteriol. 2001; 183: 1195-1204. PMID: 11157931
32. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature. 2000; 407: 762-764. PMID: 11048725
33. Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, et al. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med. 2006; 173: 1139-1144. PMID: 16497995
34. Del Porto P, Cifani N, Guarnieri S, Di Domenico EG, Mariggio MA, Spadaro F, et al. Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa. PLOS One. 2011; 6: e19970. doi: 10.1371/journal.pone.0019970 PMID: 21625641
35. Kowalski MP, Pier GB. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol. 2004; 172: 418-425. PMID: 14688350
36. Ballok AE, O'Toole GA. Pouring Salt on a Wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung. J Bacteriol. 2013; 195: 4013-4019. doi: 10.1128/JB.00339-13 PMID: 23836869
37. Goldberg JB, Pier GB. The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis. Trends Microbiol. 2000; 8: 514-520. PMID: 11121762
38. Bajmoczi M, Gadjeva M, Alper SL, Pier GB, Golan DE. Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. Am J Physiol Cell Physiol. 2009; 297: C263-277. doi: 10.1152/ajpcell.00527.2008 PMID: 19386787
39. Bomberger JM, Ye S, Maceachran DP, Koeppen K, Barnaby RL, O'Toole GA, et al. A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. PLOS Pathog. 2011; 7: e1001325. doi: 10.1371/journal.ppat.1001325 PMID: 21455491
40. Pier GB. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc Natl Acad Sci. 2000; 97: 8822-8828. PMID: 10922041
41. Zhang Y, Li X, Grassme H, Doring G, Gulbins E. Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection. J Immunol. 2010; 184: 5104-5111. doi: 10.4049/jimmunol.0902851 PMID: 20351190
42. Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol. 2006; 8: 933-944. PMID: 16921366
43. Pasyk S, Li C, Ramjeesingh M, Bear CE. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease. Biochem J. 2009; 418:185-190. doi: 10.1042/BJ20081424 PMID: 18945216
44. Wang Y, Loo TW, Bartlett MC, Clarke DM. Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein. J Biol Chem. 2007; 282: 33247-33251. PMID: 17911111
45. Kode A, Yang SR, Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res. 2006; 7: 132. PMID: 17062156
46. Su Y, Han W, Giraldo C, De Li Y, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol. 1998; 19: 819-825. PMID: 9806747
47. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002; 2: 372-377. PMID: 12033743
48. Rennolds J, Butler S, Maloney K, Boyaka PN, Davis IC, Knoell DL, et al. Cadmium regulates the expression of the CFTR chloride channel in human airway epithelial cells. Toxicol Sci. 2010; 116: 349-358. doi: 10.1093/toxsci/kfq101 PMID: 20363832
49. Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci. 1997; 94: 12088-12093. PMID: 9342367
50. Pyle LC, Fulton JC, Sloane PA, Backer K, Mazur M, Praisain J, et al. Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: potential use as a biomarker of DeltaF508 cystic fibrosis transmembrane conductance regulator rescue. Am J Respir Cell Mol Biol.2010; 43: 607-616. doi: 10.1165/rcmb.2009-0281OC PMID: 20042712
51. Zhang S, Smith N, Schuster D, Azbell C, Sorscher EJ, Rowe SM, et al. Quercetin increases cystic fibrosis transmembrane conductance regulator-mediated chloride transport and ciliary beat frequency: therapeutic implications for chronic rhinosinusitis. Am J Rhinol Allergy. 2005; 25: 307-312.
52. Caci E, Caputo A, Hinzpeter A, Arous N, Fanen P, Sonawane N, et al. Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis. Biochem J. 2008; 413: 135-142. doi: 10.1042/BJ20080029 PMID: 18366345
53. Donova MV, Nikolayeva VM, Dovbnya DV, Gulevskaya SA, Suzina NE. Methyl-beta-cyclodextrin alters growth, activity and cell envelope features of sterol-transforming mycobacteria. Microbiology. 2007; 153: 1981-1992. PMID: 17526855
54. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol. 2003; 81: 289-296. PMID: 12848850
55. van de Weert-van Leeuwen PB, van Meegen MA, Speirs JJ, Pals DJ, Rooijakkers SH, et al. Optimal Complement-Mediated Phagocytosis of Pseudomonas aeruginosa by Monocytes is CFTR-Dependent. Am J Respir Cell Mol Biol.2013; 49: 463-470 doi: 10.1165/rcmb.2012-0502OC PMID: 23617438
56. Childers M, Eckel G, Himmel A, Caldwell J. A new model of cystic fibrosis pathology: lack of transport of glutathione and its thiocyanate conjugates. Med Hypotheses. 2007; 68: 101-112. PMID: 16934416
57. Xu Y, Krause A, Hamai H, Harvey BG, Worgall TS, Worgall S. Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA. PLOS One. 2010; 5: e11004. doi: 10.1371/journal.pone.0011004 PMID: 20543983
58. Cantin AM, Bilodeau G, Ouellet C, Liao J, Hanrahan JW. Oxidant stress suppresses CFTR expression. Am J Physiol Cell Physiol. 2006; 290: C262-270. PMID: 16162662
59. Kreindler JL, Jackson AD, Kemp PA, Bridges RJ, Danahay H. Inhibition of chloride secretion in human bronchial epithelial cells by cigarette smoke extract. Am J Physiol Lung Cell Mol Physiol. 2005; 288: L894-902. PMID: 15626749
60. Barriere H, Bagdany M, Bossard F, Okiyoneda T, Wojewodka G, Gruenert D, et al. Revisiting the role of cystic fibrosis transmembrane conductance regulator and counterion permeability in the pH regulation of endocytic organelles. Mol Biol Cell. 2009; 20: 3125-3141. doi: 10.1091/mbc.E09-01-0061 PMID: 19420138
61. Radtke AL, Anderson KL, Davis MJ, DiMagno MJ, Swanson JA, O'Riordan MX. Listeria monocytogenes exploits cystic fibrosis transmembrane conductance regulator (CFTR) to escape the phagosome. Proc Natl Acad Sci. 2005; 108: 1633-1638.
62. Deriy LV, Gomez EA, Zhang G, Beacham DW, Hopson JA, Gallan AJ, et al. Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages. J Biol Chem. 2009; 284: 35926-35938. doi: 10.1074/jbc.M109.057372 PMID: 19837664
63. MacEachran DP, Ye S, Bomberger JM, Hogan DA, Swiatecka-Urban A, Stanton BA, et al. The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator. Infect Immun. 2007; 75: 3902-3912. PMID: 17502391
64. Swiatecka-Urban A, Moreau-Marquis S, Maceachran DP, Connolly JP, Stanton CR, Su JR. Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells. Am J Physiol Cell Physiol. 2006; 290: C862-872. PMID: 16236828
65. Vij N, Downey GP. The yin and yang of cystic fibrosis transmembrane conductance regulator function: implications for chronic lung disease. Am J Respir Crit Care Med. 2013; 187: 120-122. doi: 10.1164/ rccm.201211-2011ED PMID: 23322792
66. Wellhauser L, Kim Chiaw P, Pasyk S, Li C, Ramjeesingh M, Bear CE. A small-molecule modulator interacts directly with deltaPhe508-CFTR to modify its ATPase activity and conformational stability. Mol Pharmacol. 2009; 75: 1430-1438. doi: 10.1124/mol.109.055608 PMID: 19339490
67. Kim Chiaw P, Wellhauser L, Huan LJ, Ramjeesingh M, Bear CE. A chemical corrector modifies the channel function of F508del-CFTR. Mol Pharmacol. 2010; 78: 411-418. doi: 10.1124/mol.110.065862 PMID: 20501743
68. Hunter MJ, Treharne KJ, Winter AK, Cassidy DM, Land S, Mehta A. Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling. PLOS One. 2010; 5: e11598. doi: 10.1371/journal. pone.0011598 PMID: 20644644
69. Vij N, Mazur S, Zeitlin PL. CFTR is a negative regulator of NFkappaB mediated innate immune response. PLOS One. 2009; 4: e4664. doi: 10.1371/journal.pone.0004664 PMID: 19247502
70. Schroeder TH, Lee MM, Yacono PW, Cannon CL, Gerceker AA, Golan DE, et al. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci. 2002; 99: 6907-6912. PMID: 11997458
71. Zaidi T, Bajmoczi M, Golan DE, Pier GB. Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2008; 49: 1000-1009. doi: 10.1167/iovs.07-0993 PMID: 18326723
72. Cholon DM, O'Neal WK, Randell SH, Riordan JR, Gentzsch M. Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol. 2010; 298: L304-314. doi: 10.1152/ajplung.00016.2009 PMID: 20008117